23andMe’s Parkinson’s Research Community is by far the world’s largest re-contactable deeply phenotyped cohort for Parkinson’s disease research.
New Genetic Associations Found
Over the last decade data from this community has contributed significantly to new insights into Parkinson’s disease. This includes the discovery of 90 genetic variants associated with Parkinson’s disease. These findings give scientists potential pathways for future research and insight into possible new drug targets to treat Parkinson’s.
New Phenotypes
23andMe researchers have also identified more than 100 phenotypic — or non-genetic traits or characteristics — associations with Parkinson’s. This offers the potential for earlier detection of the disease. 23andMe researchers and our collaborators have also published dozens of papers on Parkinson’s. With our collaborators, we have also opened an online portal to provide qualified Parkinson’s researchers’ access to its aggregate-level, de-identified data.
As part of Parkinson's Awareness month, 23andME looks back over the now 11 years since we formed the Parkinson's Research Community and note some of what we've accomplished.
At 23andMe, we are committed to accelerating and advancing Parkinson’s disease research. So when April comes around, employees make a point of honoring Parkinson’s Awareness Month.As we’ve done in the...
Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...
Scientists at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.
April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...
After four days in Berlin attending the massive annual meeting of the International Parkinson’s and Movement Disorders Society, 23andMe Parkinson’s Community manager, Paul Cannon, PhD, came back hopeful for the...
In his last fight– the one against Parkinson’s – Muhammad Ali went the distance finally succumbing in early June to complications from a respiratory problem.He was 74. In the more...
There are many faces of Parkinson’s, Claudia’s just happens to be smiling most of the time. “I’m an optimistic person,” said the mother of two teenage boys who lives with...